keystone
If malaria elimination is a stable state, how do we get there?
'The science of malaria eradication' Keystone Symposia
Tuesday Feb 4th
The Keystone Symposium on The Science of Malaria Eradication entered its second day of activities with a focus on drug based strategies and health systems research in the elimination context. The evidence for use of single dose primaquine to clear P. falciparum infections, the new K-13 artemisinin resistance marker, and how clearing asymptomatic infections in children can improve cognition and reduce transmission all featured in the animated discussions.
'It always seems impossible until it is done' – Nelson Mandela
'The science of malaria eradication' Keystone Symposia
Monday Feb 3rd
From bioethical considerations, to mapping trends in malaria transmission with basic biology. From inspiring lessons in other eradication campaigns, to regulatory issues around tools which benefit populations, to novel genetic technologies which modify mosquitoes and the parasite life cycle. The first day of the Keystone Symposium on the science of malaria eradication set the scene for sharing and debating new discoveries and innovative approaches to malaria eradication.
Kick-off to the 'The science of malaria eradication' Keystone Symposia
Sunday Feb 2nd
'The science of malaria eradication' Keystone Symposia celebrated its first day of activities in Merida, Yucatan, with a workshop devoted to students and researchers from endemic countries that received a travel award to attend the meeting. This workshop offered the opportunity to interact with a group of international experts that discussed the role of a dynamic biomedical research agenda, including aspects relating to therapeutics, vector biology and vaccines to interrupt transmission.